Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

512
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
512

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Count your bits: fingerprint benchmarking to assess broad chemical space representation.

Journal of cheminformatics·2026
Same author

Connecting Rural Veterans: Community-Based Peer Social Interventions to Advance Health and Resource Access.

The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·2026
Same author

The Impact of Malnutrition and Multimodal Prehabilitation on Quality of Life in Head and Neck Cancer Patients Following Resection and Microvascular Reconstruction: A Cross-Sectional Study.

Journal of clinical medicine·2026
Same author

Advances in predicting T cell epitope recognition for cancer immunotherapy.

Nature cancer·2026
Same author

Homogeneous shear distribution improves NK-92 cell cytotoxicity in a clinically relevant 2 L membrane-stirred bioreactor.

Frontiers in bioengineering and biotechnology·2026
Same author

Prevalence and Correlates of Pre-Employment Drug Screens and Job Denial among Veterans with Co-Occurring Conditions.

Substance use & addiction journal·2026
Same journal

Targeting cholesterol esterification sensitizes liver cancer to CD8<sup>+</sup> T cell attack by impairing metabolic and redox resilience.

Immunity·2026
Same journal

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same journal

Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors.

Immunity·2026
Same journal

B cell-derived type I interferon sustains T cell functionality upon strong TCR stimulation during chronic infection.

Immunity·2026
Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026
Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026
See all related articles

Related Experiment Video

Updated: Jul 14, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.6K

Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.

Markus Müller1, Florian Huber2, Marion Arnaud2

  • 1Ludwig Institute for Cancer Research, University of Lausanne, Agora Center Bugnon 25A, 1005 Lausanne, Switzerland; Department of Oncology, Centre hospitalier universitaire vaudois (CHUV), Rue du Bugnon 46, 1005 Lausanne, Switzerland; Agora Cancer Research Centre, 1011 Lausanne, Switzerland; SIB Swiss Institute of Bioinformatics, Quartier Sorge, Bâtiment Amphipôle, 1015 Lausanne, Switzerland.

Immunity
|October 10, 2023
PubMed
Summary
This summary is machine-generated.

Identifying immunogenic neoantigens is key for cancer immunotherapy. This study found that neoantigen location, binding ability, and gene function predict immunogenicity, improving neoantigen selection by 30%.

Keywords:
cancer immunotherapymachine learningneoantigen prioritizationpersonalized cancer vaccine

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Related Experiment Videos

Last Updated: Jul 14, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.6K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Area of Science:

  • Immunology
  • Oncology
  • Bioinformatics

Background:

  • Accurate neoantigen selection is critical for effective cancer immunotherapy pipelines.
  • Neoantigens must bind to human leukocyte antigen (HLA) class I and be recognized by T cells.

Purpose of the Study:

  • To identify predictive features of neoantigen immunogenicity beyond standard metrics.
  • To develop and validate machine learning classifiers for improved neoantigen ranking.

Main Methods:

  • Reprocessed whole-exome sequencing and RNA sequencing data from 131 cancer patients.
  • Combined external screening assays with an in-house dataset.
  • Identified somatic mutations, neo-peptides, and assessed immunogenicity.

Main Results:

  • Identified 46,017 somatic single-nucleotide variant mutations and 1,781,445 neo-peptides.
  • Confirmed 212 mutations and 178 neo-peptides as immunogenic.
  • Neo-peptide location in HLA presentation hotspots, binding promiscuity, and oncogenicity were predictive of immunogenicity.

Conclusions:

  • Machine learning classifiers accurately predicted neoantigen immunogenicity across datasets.
  • The developed methods improved neoantigen ranking by up to 30%.
  • Provided valuable homogenized datasets for developing and benchmarking neoantigen-based immunotherapy algorithms.